Latest Industry Insights
Industry Insight
Addressing One of the Most Common Dilemmas Faced by Oncologists
Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Industry Insight
Confident Metabolite Identification for Meaningful Results in Multiomics Analyses
In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.
Industry Insight
Accelerating Single-Cell Research with Powerful Dispensing
Join us for an interview with HP's Christie Dudenhoefer, manager of Life Science Solutions, and Dr. Ryan Kelly, professor in the Department of Chemistry at Brigham Young University, to learn how HP's D100 single-cell dispenser is being utilized.
Industry Insight
What Does Sustainability Accreditation Really Mean for Scientific Companies?
With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Industry Insight
A New-Generation HPLC System Has Users at Its Heart
HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.
Industry Insight
Gene Expression Analysis in Cancer Research
We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
Industry Insight
Flagship Facility Supports Advanced Analytical Science
We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Industry Insight
Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research
Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Industry Insight
Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies
Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
Industry Insight
Increasing Throughput While Protecting Proteome Coverage
At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Advertisement